Circulating Antibody to Myelin Basic Protein in Relapsing-Remitting Multiple Sclerosis? A Comparative Group and Sequential Study by Radioimmunoassay.

Journal of Neurology, Neurosurgery and Psychiatry - United Kingdom
doi 10.1136/jnnp.41.12.1131
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis

Neurotherapeutics
NeurologyPharmacology
2017English

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis

Archives of Neurology
2009English

Cerebrovascular Reactivity and Disease Activity in Relapsing-Remitting Multiple Sclerosis

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2020English

Natalizumab: A New Treatment for Relapsing Remitting Multiple Sclerosis

Therapeutics and Clinical Risk Management
Chemical HealthPharmacologySafetyMedicineToxicologySafety ResearchPharmaceutics
2007English

Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2010English

Cognitive Impairments in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis

Multiple Sclerosis
Neurology
2008English

Stressful Events Increase Exacerbations in Relapsing-Remitting Multiple Sclerosis

BMJ
2003English

Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

Multiple Sclerosis International
Neurology
2015English

Relapsing-Remitting Multiple Sclerosis and Human Herpesvirus 6 Active Infection

Archives of Neurology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy